Raphaela Brauns

Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature

Sara Samadzadeh, Beyza Ürer, Raphaela Brauns et al. · Toxins · 2020 · 36 citations · Full text

Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study

Harald Hefter, Raphaela Brauns, Beyza Ürer et al. · Journal of Neurology · 2020 · 34 citations · Full text

Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin

Harald Hefter, Dietmar Rosenthal, Alexander Jansen et al. · Journal of Neurology · 2022 · 23 citations · Full text

Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure

Harald Hefter, Beyza Ürer, Raphaela Brauns et al. · Toxins · 2022 · 11 citations · Full text

The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany

Sara Samadzadeh, Raphaela Brauns, Dietmar Rosenthal et al. · Toxins · 2021 · 10 citations · Full text